Abstract
Objective
To investigate the pattern of brain atrophy across time in a sample of Parkinson's disease (PD) patients with and without dementia using voxelbased morphometry (VBM) analysis.
Methods
The initial sample comprised thirteen non–demented PD patients and sixteen demented patients. Longitudinal cognitive assessment and structural MRI were performed. The mean follow–up period was 25 months (SD = 5.2). From this initial group, eight PD patients with dementia (5 men and 3 women) and eleven PD patients without dementia (7 men and 4 women) were reevaluated. MRI 3D structural images were acquired and analyzed by means of the optimized VBM procedure with Statistical Parametric Mapping (SPM2).
Results
VBM analysis showed a progressive grey matter volume decrease in patients with PD without dementia in limbic, paralimbic and neocortical associative temporooccipital regions. In patients with dementia the loss mainly involved neocortical regions.
Conclusion
VBM revealed a significant loss of grey matter volume in PD patients with and without dementia with disease progression. The decrease in limbic and paralimbic regions is widespread in non–demented patients. Neocortical volume reduction is the most relevant finding in patients with dementia. This suggests that the neocortex is a substrate for dementia in Parkinson disease.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Aarsland D, Tandberg E, Larsen JP, Cummings JL (1996) Frequency of dementia in Parkinson disease. Arch Neurol 53(6):538–542
Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh–Sørensen P (2003) Prevalence and characteristics of dementia in Parkinson disease. An 8–year prospective study. Arch Neurol 60:387–392
American Psychiatric Association (2003) Manual diagnóstico y estadístico de los trastornos mentales, Cuarta edición revisada: DSM–IV–TR. Masson SA, Barcelona
Apaydin H, Ahlskog JE, Parisi JE, Boeve BF, Dickson DW (2002) Parkinson disease neuropathology. Laterdeveloping dementia and loss of the levodopa response. Arch Neurol 59:102–112
Braak H, Braak E, Yilmazer D, de Vos RA, Jansen EN, Bohl J, Jellinger K (1994) Amygdala pathology in Parkinson’s disease. Acta Neuropathol (Berl) 88:493–500
Braak H, Braak E (2000) Pathoanatomy of Parkinson’s disease. J Neurol 247 (Suppl 2):II/3–II/10
Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211
Burn DJ (2004) Cortical Lewy body disease. J Neurol Neurosurg Psychiatry 75:175–178
Burton EJ, McKeith IG, Burn DJ, Williams ED, O’Brien JT (2004) Cerebral atrophy in Parkinson’s disease with and without dementia: a comparison with Alzheimer’s disease, dementia with Lewy bodies and controls. Brain 127:791–800. DOI: 10.1093/brain/awh088
Calopa M, Tolosa E, Ferrer I, Rey MJ, Cardozo A, Martí MJ, Ribalta T (2002) Cortical Lewy bodies in Parkinson’s disease with dementia. In: Tolosa E, Schulz JB, McKeith IG, Ferrer I (eds) Neurodegenerative disorders associated with α–Synuclein pathology. Medicina stm Editores, SL, Barcelona, pp 127–134
Camicioli R, Moore MM, Kinney A, Corbridge E, Glassberg K, Kaye JA (2003) Parkinson's disease is associated with hippocampal atrophy. Mov Disord 18(7):784–790
Daniel SE, Lees AJ (1993) Parkinson's Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl 39:165–172
de la Monte SM, Wells SE, Hedley– Whyte ET, Growdon JH (1989) Neuropathological distinction between Parkinson’s dementia and Parkinson’s plus Alzheimer's disease. Ann Neurol 26:309–320
De Vos RA, Jansen EN, Stam FC, Ravid R, Swaab DF (1995) 'Lewy body disease': clinico–pathological correlations in 18 consecutive cases of Parkinson's disease with and without dementia. Clin Neurol Neurosurg 97:13–22
Diederich NJ, Goetz CG, Stebbins GT (2005) Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: focused review and a new integrative model. Mov Disord 20(2):130–140. DOI: 10.1002/mds 0.20308
Dubois B, Pillon B (1997) Cognitive deficits in Parkinson's disease. J Neurol 244:2–8
Factor SA, Feustel PJ, Friedman JH, Comella CL, Goetz CG, Kurlan R, Parsa M, Pfeiffer R and the Parkinson Study Group (2003) Longitudinal outcome of Parkinson's disease patients with psychosis. Neurology 60:1756–1761
Fahn S, Elton RL and members of the UPDRS development committee (1987) Unified Idiopathic Parkinson's disease Rating Scale. In: Fahn S, Marsden CD, Calne D, Goldstein M (eds) Recent developments in Parkinson's disease (Vol. 2). Florham Park, New Jersey, Mac Millan Healthcare Information, USA, pp 153–164
Fearnley JM, Lees AJ (1991) Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114:2283–2301
Folstein MF, Folstein SE, McHugh PR (1975) "Mini–mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198
Goetz CG, Leurgans S, Pappert EJ, Raman R, Stemer AB (2001) Prospective longitudinal assessment of hallucinations in Parkinson's disease. Neurology 57:2078–2082
Goldman WP, Baty JD, Buckles VD, Sahrmann S, Morris JC (1998) Cognitive and motor functioning in Parkinson disease. Arch Neurol 55:674–680
Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS (2001) A voxel–based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14:21–36. DOI: 10.1006/nimg 0.2001.0786
Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62
Harding AJ, Broe GA, Halliday GM (2002) Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 125:391–403
Hu MT, White SJ, Chaudhuri KR, Morris RG, Bydder GM, Brooks DJ (2001) Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline. J Neural Transm 108:571–580
Hurtig HI, Trojanowski JQ, Galvin J, Ewbank D, Schmidt ML, Lee VM, Clark CM, Glosser G, Stern MB, Gollomp SM, Arnold SE (2000) Alpha–synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology 54(10):1916–1921
Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I, Stern M, Tanner C, Weiner W and the Parkinson Study Group (1990) Variable expression of Parkinson's disease: A base–line analysis of the DATATOP cohort. Neurology 40:1529–1534
Kaasinen V, Aalto S, Någren K, Hietala J, Sonninen P, Rinne JO (2003) Extrastriatal dopamine D2 receptors in Parkinson's disease: a longitudinal study. J Neural Transm 110:591–601. DOI: 10.1007/s00702–003–0816–x
Kawabata K, Tachibana H, Sugita M (1991) Cerebral blood flow and dementia in Parkinson's disease. J Geriatr Psychiatry Neurol 4(4):194–203
Kikuchi A, Takeda A, Kimpara T, Nakagawa M, Kawashima R, Sugiura M, Kinomura S, Fukuda H, Chida K, Okita N, Takase S, Itoyama Y (2001) Hypoperfusion in the supplementary motor area, dorsolateral prefrontal cortex and insular cortex in Parkinson's disease. J Neurol Sci 193:29–36
Levy G, Jacobs DM, Tang M, Côté LJ, Louis ED, Alfaro B, Mejia H, Stern Y, Marder K (2002a) Memory and executive function impairment predict dementia in Parkinson's disease. Mov Disord 17(6):1221–1226. DOI: 10.1002/mds 0.10280
Levy G, Schupf N, Tang M, Cote LJ, Louis ED, Mejia H, Stern Y, Marder K (2002b) Combined effect of age and severity on the risk of dementia in Parkinson's disease. Ann Neurol 51:722–729. DOI: 10.1002/ana 0.10219
Lezak MD, Howieson DB, Loring DW, Hannay HJ, Fischer JS (2004) Neuropsychological assessment. 4th ed. Oxford University Press Inc., New York
Marttila RJ, Rinne UK (1976) Epidemiology of Parkinson's disease in Finland. Acta Neurol Scand 53(2):81–102
Matsuda H, Kitayama N, Ohnishi T, Asada T, Nakano S, Sakamoto S, Imabayashi E, Katoh A (2002) Longitudinal evaluation of both morphologic and functional changes in the same individuals with Alzheimer's disease. J Nucl Med 43:304–311
Mattila PM, Rinne JO, Helenius H, Dickson DW, Röyttä M (2000) Alphasynuclein– immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease. Acta Neuropathol (Berl)100:285–290
Mayeux R, Denaro J, Hemenegildo N, Marder K, Tang MX, Cote LJ, Stern Y (1992) A population–based investigation of Parkinson's disease with and without dementia. Relationship to age and gender. Arch Neurol 49(5):492–497
Nurmi E, Bergman J, Eskola O, Solin O, Vahlberg T, Sonninen P, Rinne JO (2003) Progression of dopaminergic hypofunction in striatal subregions in Parkinson's Disease using [18F]CFT PET. Synapse 48:109–115. DOI: 10.1002/syn 0.10192
Perry EK, Curtis M, Dick DJ, Candy JM, Atack JR, Bloxham CA, Blessed G, Fairbairn A, Tomlinson BE, Perry RH (1985) Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. J Neurol Neurosurg Psychiatry 48:413–421
Resnick SM, Pham DL, Kraut MA, Zonderman AB, Davatzikos C (2003) Longitudinal magnetic resonance imaging studies of older adults: a shrinking brain. J Neurosci 23(8):3295–3301
Staffen W, Mair A, Unterrainer J, Trinka E, Ladurner G (2000) Measuring the progression of idiopathic Parkinson's disease with [123 I] β–CIT SPECT. J Neural Transm 107:543–552
Summerfield C, Junqué C, Tolosa E, Salgado–Pineda P, Gómez–Ansón B, Martí MJ, Pastor P, Ramírez–Ruiz B, Mercader J (2005) Structural brain changes in Parkinson disease with dementia. A voxel–based morphometry study. Arch Neurol 62:281–285
Tachibana H, Kawabata K, Tomino Y, Sugita M, Fukuchi M (1993) Brain perfusion imaging in Parkinson's disease and Alzheimer's disease demonstrated by three–dimensional surface display with 123I–iodoamphetamine. Dementia 4(6):334–341
Tisserand DJ, van Boxtel MP, Pruessner JC, Hofman P, Evans AC, Jolles J (2004) A Voxel–based morphometric study to determine differences in gray matter density associated with age and cognitive change over time. Cereb Cortex 14:966–973; DOI: 10.1093/cercor/bhh057
Visser PJ, Verhey FR, Hofman PA, Scheltens P, Jolles J (2002) Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment. J Neurol Neurosurg Psychiatry 72:491–497
Zweig RM, Cardillo JE, Cohen M, Giere S, Hedreen, JC (1993) The locus ceruleus and dementia in Parkinson's disease. Neurology 43:986–991
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ramírez–Ruiz, B., Martí, M.J., Tolosa, E. et al. Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia. J Neurol 252, 1345–1352 (2005). https://doi.org/10.1007/s00415-005-0864-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-005-0864-2